Albemarle Corporation (NYSE:ALB)’s share price hit a new 52-week high on Monday after Instinet raised their price target on the stock from $134.00 to $146.00. Instinet currently has a buy rating on the stock. Albemarle Corporation traded as high as $130.83 and last traded at $130.73, with a volume of 889,304 shares changing hands. The stock had previously closed at $127.29.
Other equities analysts have also issued research reports about the company. Royal Bank of Canada reiterated a “buy” rating and issued a $136.00 price target on shares of Albemarle Corporation in a research note on Friday, July 14th. Aegis reiterated a “buy” rating on shares of Albemarle Corporation in a research note on Friday, July 7th. Zacks Investment Research upgraded Albemarle Corporation from a “hold” rating to a “buy” rating and set a $121.00 price target on the stock in a research note on Friday, July 7th. Jefferies Group LLC reiterated a “buy” rating and issued a $120.00 price target on shares of Albemarle Corporation in a research note on Friday, June 16th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $36.00 price target on shares of Albemarle Corporation in a research note on Thursday, June 29th. Seven research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $112.50.
In related news, EVP Karen G. Narwold sold 11,500 shares of the business’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $115.95, for a total transaction of $1,333,425.00. Following the sale, the executive vice president now owns 36,620 shares in the company, valued at approximately $4,246,089. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Matthew Juneau sold 5,397 shares of the business’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $115.77, for a total value of $624,810.69. Following the sale, the executive vice president now owns 360 shares in the company, valued at approximately $41,677.20. The disclosure for this sale can be found here. Insiders have sold a total of 91,897 shares of company stock worth $10,215,486 in the last 90 days. 0.74% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently modified their holdings of ALB. Advisors Asset Management Inc. grew its position in Albemarle Corporation by 69.9% during the 1st quarter. Advisors Asset Management Inc. now owns 5,027 shares of the specialty chemicals company’s stock worth $531,000 after acquiring an additional 2,069 shares during the last quarter. UBS Asset Management Americas Inc. lifted its holdings in Albemarle Corporation by 9.5% during the 1st quarter. UBS Asset Management Americas Inc. now owns 283,138 shares of the specialty chemicals company’s stock worth $29,911,000 after buying an additional 24,621 shares during the period. Karp Capital Management Corp acquired a new position in Albemarle Corporation during the 1st quarter worth about $3,690,000. Engineers Gate Manager LP acquired a new position in Albemarle Corporation during the 1st quarter worth about $401,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in Albemarle Corporation by 29.5% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,350 shares of the specialty chemicals company’s stock worth $882,000 after buying an additional 1,902 shares during the period. Institutional investors and hedge funds own 83.73% of the company’s stock.
The company has a market cap of $14.88 billion, a PE ratio of 17.22 and a beta of 1.61. The company has a 50-day moving average of $117.92 and a 200 day moving average of $111.37.
Albemarle Corporation (NYSE:ALB) last released its earnings results on Monday, August 7th. The specialty chemicals company reported $1.13 EPS for the quarter, beating the Zacks’ consensus estimate of $1.11 by $0.02. The business had revenue of $737.25 million for the quarter, compared to analysts’ expectations of $735.50 million. Albemarle Corporation had a return on equity of 11.59% and a net margin of 31.49%. The firm’s revenue was up 10.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.93 earnings per share. On average, analysts anticipate that Albemarle Corporation will post $4.37 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, October 2nd. Investors of record on Friday, September 15th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $1.28 dividend on an annualized basis and a yield of 0.95%. Albemarle Corporation’s dividend payout ratio is presently 16.41%.
ILLEGAL ACTIVITY NOTICE: This news story was originally published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.chaffeybreeze.com/2017/09/20/albemarle-corporation-alb-reaches-new-52-week-high-on-analyst-upgrade.html.
Albemarle Corporation Company Profile
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.
Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.